Two Covid-19 antibody drugs developed in China have yielded promising results in studies and clinical trials, researchers said during an academic conference over the weekend.
The trial will enroll approximately 140 adults at nearly 20 blood cancer clinical research centres in the country.
Today was announced the first patient enrolled in its phase 3 ENSURE program.
Mexico Has Immense Clinical Research Capabilities And Benefits. Conducting Clinical Trials In Mexico Grants You Affordable Costs And A Robust Regulatory System.
The first patient has been dosed as part of its Phase I/IIa CICILIA clinical trial.
The university has launched a Phase I trial to test the vaccine in human volunteers and the first vaccinations take place on Thursday.
Today was announced the dosing of the first cohort of its Phase 1 clinical trial.
At week 24, 55.5% of the subjects receiving risankizumab had an ACR20 response against 31.3% in the placebo arm.
The country is the first to authorize the drug, which is the first shown to successfully treat COVID-19.
News follows FDA approval for multi-center, pivotal trial enabled by TIGERTRIEVER 13, the smallest thrombectomy device designed for distal vessels.